Novanta Inc. with ticker code (NOVT) now have 2 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between $162.00 and $150.00 suggesting an average Analsyt target price of $156.00. Given that the stocks previous close was at $143.93 and the analysts are correct then there would likely be a percentage uptick in value of 8.4%. There is a 50 day moving average of $139.82 and the 200 day moving average is $156.71. The market cap for the company is 5.17B. The stock price for the company is currently $144.28 USD
The potential market cap would be $5,600,007,218 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 68.38, revenue per share of $24.81 and a 6.56% return on assets.
Novanta Inc. is a global supplier of core technology solutions to medical and advanced industrial original equipment manufacturers. Its segments include Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide (CO2) laser, solid state laser, ultrafast laser, and optical light engine products to customers worldwide. The Vision segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorder and video integration technologies. The Precision Motion segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles to customers worldwide.
